Product Information
TIAGABINE HCL 16 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $6.0268 per EA under NDC 00093807656. Its NADAC has been published 78 times since Nov 20, 2024.
Strength
16 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093807656
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/21/2025
Active Ingredients
TIAGABINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020646On Market Since
3/9/2018
Pharmacological Classes
Price Statistics
The NADAC for TIAGABINE HCL 16 MG TABLET has been published 78 times since Nov 20, 2024, and over the history we have for it it has declined 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0268 per EA |
|---|---|
| All-time high | $6.4888 (Mar 12, 2025) |
| All-time low | $6.0268 (Apr 23, 2025) |
| 52-week high | $6.0268 |
| 52-week low | $6.0268 |
| Median price | $6.0268 |
| Average price | $6.1423 |
| Largest weekly change | -3.7% (Apr 23, 2025) |
| Weeks tracked | 78 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIAGABINE HCL 16 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TIAGABINE HCL 16 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $6.0268 per EA (NDC 00093807656), effective May 13, 2026.
How has the price of TIAGABINE HCL 16 MG TABLET changed over time?
Over the history we have for it, the NADAC for TIAGABINE HCL 16 MG TABLET has declined 7.1%. It has been tracked across 78 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for TIAGABINE HCL 16 MG TABLET?
Since Nov 20, 2024, the NADAC for TIAGABINE HCL 16 MG TABLET has ranged from a low of $6.0268 (Apr 23, 2025) to a high of $6.4888 (Mar 12, 2025), with a median of $6.0268 per EA.
Are there cheaper alternatives to TIAGABINE HCL 16 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TIAGABINE HCL 16 MG TABLET, but none are currently priced below it.
Who manufactures TIAGABINE HCL 16 MG TABLET?
TIAGABINE HCL 16 MG TABLET (NDC 00093807656) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification